HK1029124A1 - Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them. - Google Patents

Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.

Info

Publication number
HK1029124A1
HK1029124A1 HK00108444A HK00108444A HK1029124A1 HK 1029124 A1 HK1029124 A1 HK 1029124A1 HK 00108444 A HK00108444 A HK 00108444A HK 00108444 A HK00108444 A HK 00108444A HK 1029124 A1 HK1029124 A1 HK 1029124A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
peptide analogues
analogues
peptide
Prior art date
Application number
HK00108444A
Other languages
English (en)
Inventor
Remi Delansorne
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of HK1029124A1 publication Critical patent/HK1029124A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
HK00108444A 1997-06-02 2000-12-28 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them. HK1029124A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97401212A EP0882736A1 (fr) 1997-06-02 1997-06-02 Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
PCT/EP1998/002802 WO1998055505A1 (fr) 1997-06-02 1998-05-06 Analogues de peptides de lh-rh, utilisation de ces derniers et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
HK1029124A1 true HK1029124A1 (en) 2001-03-23

Family

ID=8229769

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108444A HK1029124A1 (en) 1997-06-02 2000-12-28 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.

Country Status (38)

Country Link
US (1) US6586402B1 (fr)
EP (2) EP0882736A1 (fr)
JP (1) JP4346115B2 (fr)
KR (1) KR100582510B1 (fr)
CN (1) CN1134450C (fr)
AP (1) AP1195A (fr)
AR (1) AR011734A1 (fr)
AT (1) ATE204297T1 (fr)
AU (1) AU746132B2 (fr)
BR (1) BR9809910A (fr)
CA (1) CA2292846C (fr)
CO (1) CO4790174A1 (fr)
CZ (1) CZ299308B6 (fr)
DE (1) DE69801369T2 (fr)
DK (1) DK0984982T3 (fr)
DZ (1) DZ2509A1 (fr)
EE (1) EE03879B1 (fr)
ES (1) ES2166166T3 (fr)
HK (1) HK1029124A1 (fr)
HU (1) HUP0003592A3 (fr)
ID (1) ID24520A (fr)
IL (1) IL133210A0 (fr)
JO (1) JO2034B1 (fr)
MA (1) MA26502A1 (fr)
MY (1) MY122262A (fr)
NO (1) NO321786B1 (fr)
NZ (1) NZ501463A (fr)
OA (1) OA11305A (fr)
PE (1) PE84999A1 (fr)
PL (1) PL195474B1 (fr)
PT (1) PT984982E (fr)
RU (1) RU2212247C2 (fr)
SI (1) SI0984982T1 (fr)
TN (1) TNSN98075A1 (fr)
TR (1) TR199902997T2 (fr)
TW (1) TW479062B (fr)
WO (1) WO1998055505A1 (fr)
ZA (1) ZA983992B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
CA2462046A1 (fr) * 2000-10-13 2002-04-18 Monash University Ameliorations de l'acceptation d'un greffon par manipulation de la regeneration thymique
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
DE102004033902A1 (de) * 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
CN105384807A (zh) * 2005-12-14 2016-03-09 Ambrx公司 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN110133299A (zh) * 2012-03-18 2019-08-16 株式会社资生堂 疾病样品分析装置、分析系统及分析方法
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) * 2022-01-10 2022-03-29 浙江湃肽生物有限公司南京分公司 醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2424287A1 (de) * 1974-05-18 1975-12-04 Hoechst Ag Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
WO1989007450A1 (fr) * 1988-02-10 1989-08-24 Abbott Laboratories Analogues de l'hormone de liberation de l'hormone de luteinisation (lhrh)
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EE9900546A (et) 2000-06-15
MY122262A (en) 2006-04-29
MA26502A1 (fr) 2004-12-20
JP4346115B2 (ja) 2009-10-21
PL337235A1 (en) 2000-08-14
DZ2509A1 (fr) 2003-01-25
JO2034B1 (en) 1999-05-15
HUP0003592A3 (en) 2001-05-28
CN1134450C (zh) 2004-01-14
DK0984982T3 (da) 2001-11-12
US6586402B1 (en) 2003-07-01
TW479062B (en) 2002-03-11
ATE204297T1 (de) 2001-09-15
ZA983992B (en) 1998-11-20
CZ299308B6 (cs) 2008-06-11
ES2166166T3 (es) 2002-04-01
CA2292846A1 (fr) 1998-12-10
AP9901702A0 (en) 1999-12-31
NO995891L (no) 2000-02-01
BR9809910A (pt) 2000-08-01
DE69801369D1 (de) 2001-09-20
ID24520A (id) 2000-07-20
CO4790174A1 (es) 1999-05-31
AP1195A (en) 2003-08-18
NO995891D0 (no) 1999-12-01
EP0882736A1 (fr) 1998-12-09
TNSN98075A1 (fr) 2005-03-15
NO321786B1 (no) 2006-07-03
AU7654198A (en) 1998-12-21
CN1263535A (zh) 2000-08-16
CZ432999A3 (cs) 2000-06-14
OA11305A (en) 2003-08-25
TR199902997T2 (xx) 2000-03-21
NZ501463A (en) 2001-07-27
AU746132B2 (en) 2002-04-18
AR011734A1 (es) 2000-08-30
RU2212247C2 (ru) 2003-09-20
CA2292846C (fr) 2009-12-08
EP0984982A1 (fr) 2000-03-15
PE84999A1 (es) 1999-09-15
HUP0003592A2 (hu) 2001-02-28
SI0984982T1 (en) 2002-02-28
PT984982E (pt) 2002-02-28
EP0984982B1 (fr) 2001-08-16
DE69801369T2 (de) 2002-05-16
WO1998055505A1 (fr) 1998-12-10
KR100582510B1 (ko) 2006-05-23
EE03879B1 (et) 2002-10-15
JP2002502396A (ja) 2002-01-22
KR20010013286A (ko) 2001-02-26
PL195474B1 (pl) 2007-09-28
IL133210A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
HK1029124A1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.
ZA988585B (en) Pharmaceutical compositions containing plasma protein.
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
HUP0003349A3 (en) Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
HK1022271A1 (en) Pharmaceutical aerosol composition.
HUP0102372A3 (en) Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP0104579A3 (en) Glp-1 analogues, pharmaceutical compositions comprising thereof and their use
PH31059A (en) Pharmaceutical compositions comprising cyclosporins.
IL131293A (en) Pyrazine compounds, their preparation and pharmaceutical compositions comprising them
ZA974735B (en) Pharmaceutical compositions.
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP0004561A3 (en) Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
ZA977104B (en) Pharmaceutical compositions.
ZA989680B (en) Pharmaceutical composition.
IL135723A (en) 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
HK1022853A1 (en) Pharmaceutical compositions.
ZA987392B (en) Pharmaceutical composition.
ZA9710254B (en) LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
ZA972602B (en) Pharmaceutical compositions.
IL118815A (en) N,N-diethyl-8,8-dipropyl-2-azaspiro¬4.5¾decane-2-propanamine dimaleate and pharmaceutical compositions comprising it
ZA986800B (en) Oligo-Thiophenes useful as antimetastatic agents, a preparation thereof and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120506